Journal article
Granulocyte-macrophage colony-stimulating factor is neuroprotective in experimental traumatic brain injury
SR Shultz, XL Tan, DK Wright, SJ Liu, BD Semple, L Johnston, NC Jones, AD Cook, JA Hamilton, TJ O'Brien
Journal of Neurotrauma | MARY ANN LIEBERT, INC | Published : 2014
Abstract
Traumatic brain injury (TBI) is an international health concern with a complex pathogenesis resulting in major long-term neurological, neurocognitive, and neuropsychiatric outcomes. Although neuroinflammation has been identified as an important pathophysiological process resulting from TBI, the function of specific inflammatory mediators in the aftermath of TBI remains poorly understood. Granulocyte-macrophage colony-stimulating factor (GM-CSF) is an inflammatory cytokine that has been reported to have neuroprotective effects in various animal models of neurodegenerative disease that share pathological similarities with TBI. The importance of GM-CSF in TBI has yet to be studied, however. We ..
View full abstractGrants
Funding Acknowledgements
We would like to thank Thanh Nguyen for assistance with immunofluorescence experiments. This study was funded by grants to T.O.B. from the National Health and Medical Research Council (NHMRC #1006077), the Victorian Transport Accident Commission (Victorian Neurotrauma Initiative Grant #DNP13), and the Royal Melbourne Hospital Neuroscience Foundation, a fellowship from the Canadian Institute of Health Research to S. S., and a Senior Principal Research Fellowship from NHMRC to J.A.H..